Module2_Home_banner
Module2_Home_banner
This content is intended for healthcare professionals only

Module 2

How Dymista® CONTROL can
break the hay fever struggle

 

2 actives, 1 spray:1 fast, effective relief2,3

Dymista® CONTROL is the ONLY OTC nasal spray in the UK to combine inflammation-fighting steroid and anti-allergy antihistamine,1,4 providing rapid relief from bothersome hay fever from 5 minutes.3

How and why Dymista® CONTROL works:

• Antihistamines block the effects of histamine to alleviate symptoms like sneezing, a runny nose and itching. When used intranasally, the histamine release is blocked directly where it’s needed, giving patients quick relief.5

• Steroids reduce the inflammation in the nasal passages to treat nasal congestion, itching and sneezing.5

Dymista® CONTROL is faster and more effective at reducing all EYE and NOSE symptoms of hay fever than a steroid spray alone (FP) 2 or in combination with oral antihistamine (FP+LORA).3

Itchy, red, watery eyes

Sneezing & itching

A runny nose & nasal congestion

• Dymista® CONTROL is the only OTC nasal spray in the UK to combine inflammation-fighting steroid and anti-allergy antihistamine1,4

• It is faster and more effective at reducing all eye and nose symptoms of hay fever than a steroid spray alone (FP)2 or than a steroid spray2 + oral antihistamine (LORA).3

• As recommended by The BSACI, when hay fever is moderate-to-severe and remains uncontrolled, step up to a combined nasal spray (e.g., Dymista® CONTROL)5

Module 2 summary

bottle
bottle

Module 3

Using Dymista® CONTROL

AZE = azelastine hydrochloride; BSACI = The British Society for Allergy & Immunology; FP = fluticasone propionate; LORA = loratadine; OTC = over-the-counter.

Click here for Product information

References

1.Dymista® CONTROL Summary of Product Characteristics. Available online: https://www.medicines.org.uk/emc/product/100435/smpc/print [Accessed: February 2026]. 2. Meltzer E, et al. Int Arch Allergy Immunol. 2013;161:369–377. 3. Bousquet J, et al. J Allergy Clin Immunol Pract. 2018;6(5):1726–1732. 4. OTC Directory. Available online: https://www.otcdirectory.co.uk/ [Accessed: February 2026]. 5. Scadding G, et al. Clin Exp Allergy. 2017;47:856–889.

UK-DTC-2026-00022 March 2026

X